Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up

Figure 2

(a) Long-term mean BCVA change from baseline. (b) Mean BCVA change from baseline according to previous treatment status. Note: variance is expressed in form of standard error of the mean; data depicted as dotted lines must be interpreted with caution as it represents a sample size of n < 30. ETDRS and Snellen equivalents were calculated from LogMAR values.

(a)

(b)